This page shows the latest difficult-to-treat cancers news and features for those working in and with pharma, biotech and healthcare.
Tavros will receive $17.5m in a cash upfront payment from Vividion, according to the deal. ... undruggable. “We’re thrilled to launch our work with Vividion and harness our combined expertise to reach patients with difficult-to-treat cancers by
While CAR-T therapy has shown promise in blood cancers, solid tumours present additional challenges. ... be crucial in providing important therapies for difficult to treat cancers.".
a promising new modality to Regeneron's toolkit of potential approaches for difficult-to-treat cancers. ... We look forward to welcoming the Checkmate team and their complementary scientific acumen to the Regeneron family.".
The site, situated in the US, is set to produce Kite’s FDA-approved CAR T-cell therapy used to treat blood cancers. ... strengthen our ability to meet the needs of people living with difficult-to-treat blood cancers,” said Christi Shaw, CEO of Kite.
dosed adenosine receptor antagonist, TT-702, for the treatment of patients with a range of difficult-to-treat cancers. ... treat cancers, which is why we are so delighted that we have successfully advanced TT-702 into human trials with Teon, safely
advanced or recurrent disease have limited options available to them once the disease progresses following platinum-based chemotherapy. ... The phase 3 Study 309/KEYNOTE-775 trial demonstrates the ongoing commitment that Eisai and Merck share in
More from news
Approximately 1 fully matching, plus 24 partially matching documents found.
Amgen Oncology, one of the leading developers of innovative therapies for novel targets in difficult-to-treat cancers, is working to bring new hope for transforming clinical outcomes for patients with ... Visit AmgenOncology.com to learn more about the
What is the central focus of Crescendo’s research? The company is focused on T-cell enhancement to develop new ways to treat difficult cancer types. ... success – or to make advances in those cancers that are still difficult to treat in this way.
Radiosurgery has greatest application in patients with difficult-to-treat cancers such as brain tumours. ... This was a tough ask of Pegasus as our technology is highly complex and it can be difficult to get journalists to understand its potential, let
More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.
No results were found
Wave combine scientific, medical and brand expertise to deliver clinically focused programmes that are trusted by HCPs, drive better patient...